0775:HKG
CK Life Sciences Intl (Holdings) Inc
0,51 HKD
0,00%
(0,00) 1D
16-окт., 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0775...
Open
0,51 HKD
High
0,52 HKD
Low
0,51 HKD
Mkt. cap
4,90 млд
Avg. vol.
1,66 млн
Volume
956,00 миң
52-wk high
1,02 HKD
52-wk low
0,51 HKD
EPS
-0,01 HKD
Shares outstanding
9,61 млд
No. of employees
2 миң
Open
0,51 HKD
High
0,52 HKD
Low
0,51 HKD
Mkt. cap
4,90 млд
Avg. vol.
1,66 млн
Volume
956,00 миң
52-wk high
1,02 HKD
52-wk low
0,51 HKD
EPS
-0,01 HKD
Shares outstanding
9,61 млд
No. of employees
2 миң
News stories
From web sources and news partners
AskTraders.com
·
47 мүнөт мурун
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Foreign Policy Journal
·
1 саат мурун
Rigetti Computing (NASDAQ: RGTI) Stock Drops 21% In A Month As Quantum Sector Faces Commercialization Pressure
Traders Union
·
1 саат мурун
Peter Tuchman: Nasdaq posts worst week since April 2025 tariff selloff as S&P 500 loses $1.3 trillion
Yahoo Finance
·
10 саат мурун
Michael Burry Warns of a Stock Market ‘Supervolcano’
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc